| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.6M | — | +6.3% |
| Cost of Revenue | $3.9M | — | +0.7% |
| Gross Profit | $1.7M | — | +22.0% |
| R&D Expense | $48K | — | -21.3% |
| SG&A Expense | $890K | — | +4.7% |
| Operating Income | $350K | — | +614.7% |
| Net Income | $509K | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.8M | +25.6% | +79.1% |
| Inventory | $1.7M | -16.8% | -34.3% |
| Current Assets | $9.9M | +4.9% | +7.3% |
| Total Assets | $11.3M | +3.6% | +5.2% |
| Current Liabilities | $5.0M | -1.3% | +22.7% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$167K | — | -421.9% |
| +2136.0% |
| EPS (Basic) | $0.05 | — | — |
| EPS (Diluted) | $0.05 | — | — |
| $5.9M |
| -2.2% |
| +17.3% |
| Stockholders' Equity | $5.4M | +10.7% | -5.5% |